Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Vascular-Dementia-2020

About Conference


We invites all the participants from all over the world to attend 12th International Conference on Vascular dementia during June 22-23, 2020 at Prague | Czech Republic with the Theme: Exploring the Challenges Concerning Excellence in Dementia Research and Care,which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Why to attend??

Vascular Dementia Conference 2020 is a unique forum to bring together worldwide distinguished academics in the field of Neuroscience and Neurology, Nutrition, Researchers, Public health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the Research and Development.

Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Vascular Dementia. A Unique Opportunity for Advertisers and Sponsors at this International event.

Sessions/ Tracks

Vascular Dementia 2020 has been planned and implemented in accordance with the accreditation requirementsand policies of the Accreditation Committee

This educational activity will be accredited with CME and CPD Credits

Attendance at this meeting will enable you to:

  •  
    • Be part of a rich scientific programme incorporating the latest developments in preclinical neurodegenerative diseases like Dementia and Alzheimer's Diseases
    • Understand the shift towards prevention and early diagnosis of neurodegenerative disease as the future of research in the field
    • Join key opinion leaders in discussing regulatory and ethical implications of this research in clinical practice.
    • Network with speakers and other leading experts across disciplines

Session on:

Session 1Dementia

Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer's disease. Vascular dementia, which occurs after a stroke, is the second most common dementia type. But there are many other conditions that can cause symptoms of dementia, including some that are reversible, such as thyroid problems and vitamin deficiencies. Dementia is a syndrome that involves severe loss of cognitive abilities as a result of disease or injury. Dementia caused by traumatic brain injury is often static, whereas dementia caused by neurodegenerative disorders, such as Alzheimer's disease.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 2Vascular dementia

Vascular dementia is the broad term for dementia associated with problems of circulation of blood to the brain. There are a number of different types of Vascular dementia. Two of the most common are Multi-infarct dementia and Binswanger's disease. The multi-infarct dementia (MID) and vascular intellectual impedance is dementia caused by issues in the supply of blood to the mind, normally a progression of minor strokes. People with vascular dementiagive dynamic subjective hindrance, intensely or sub acutely as in mellow psychological debilitation, every now and again step-wise, after various cerebrovascular occasions (strokes). A few people may seem to enhance amongst occasions and decrease after more noiseless strokes. A quickly decaying condition may prompt demise from a stroke, coronary illness, or infection. Vascular dementia can be caused by ischemic or hemorrhagic infarcts influencing numerous mind regions, including the foremost cerebral supply route domain, the parietal projections, or the cingulate gurus.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Sessiom 3: Lewy body Dementia

Lewy body is also known as dementia with Lewy bodies, with Lewy body dementia is the second most common type of progressive dementia after Alzheimer's disease dementia. Protein deposits, called Lewy bodies, develop in nerve cells in the brain regions involved in thinking, memory and movement (motor control).

Lewy body dementia is also causes a progressive decline in mental abilities. The people with Lewy body dementia may experience visual hallucinations and changes in the alertness and attention and other effects include Parkinson's disease-like symptoms such as rigid muscles, slow movement and tremors.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 4: Amyloid Imaging in Dementia

Amyloid imaging is a technique performed in nuclear medicine. It uses PET ligands that allow in vivo detection of amyloid plaques, a core pathologic feature of Alzheimer disease  and dementia.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 5: Alzheimers Disease

Alzheimer's disease (AD) is the most common form of dementia among older people. Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. AD begins slowly. It first involves the parts of the brain that control thought, memory and language. People with AD may have trouble remembering things that happened recently or names of people they know. A related problem, mild cognitive impairment (MCI), causes more memory problems than normal for people of the same age. Many, but not all, people with MCI will develop AD.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 6: Neurodegenerative Diseases

Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain. Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally don’t reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Examples of neurodegenerative diseases include Parkinson’s, Alzheimer’s, and Huntington’s disease.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 7: Brain diseases

Brain Diseases come in different forms of Infections, trauma, stroke, seizures, and tumors are some of the major categories of brain diseases. Here's an overview of various diseases of the brain

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 8: Ageing and Dementia

Almost 42% of people over the age of 64 experience some form of memory loss. When there is no underlying medical condition causing this memory loss, it is known as "age-associated memory impairment," which is considered a part of the normal aging process.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 9: Dementia Care Management

Dementia care management was provided at the homes of patients with dementia. Dementia care management is a model of collaborative care, defined as a complex intervention aiming to provide optimal treatment and care for patients with dementia and support caregivers using a computer-assisted assessment determining a personalized array of intervention modules and subsequent success monitoring. Dementia care management was targeted at the individual patient level and was conducted by nurses with dementia care-specific qualifications.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 10: Dementia Nursing

Caregivers of dementia patients need to understand dementia so that they can understand what the patient is going through. They need to know about underlying diseases, and how these may affect the progress of dementia. They also need to know what sort of behavior to expect. Understanding these helps them plan for their caregiving and to cope with the situation effectively, and with less stress.

 

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

Session 11Treating Dementia

Treatment of dementia begins with the treatment of the underlying disease, where possible. The underlying causes of nutritional, hormonal, tumour-caused or drug-related dementia may be reversible to some extent. For many other diseases, such as Alzheimer's disease (AD), no cure has yet been discovered. However, improvement of cognitive and behavioural symptoms can be achieved through a combination of appropriate medications and other treatments, including psychotherapy.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 12: Neuropharmacology

Neuropharmacology is an extremely wide locale of science that includes numerous parts of the sensory system from single neuron control to whole ranges of the cerebrum, spinal line, and fringe nerves. To better comprehend the premise behind medication advancement, one should first see how neurons speak with each other. This article will concentrate on both behavioral and atomic neuropharmacology; the real receptors, particle channels, and neurotransmitters controlled through medication activity and how individuals with a neurological issue advantage from this medication activity.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 13: Novel therapeutics

The purpose of the session is to consider the use of novel therapeutics for the treatment of dementia and Neurological disorders, Multiple Sclerosis etc. Novel therapeutics includes use of nanotechnology to treat Neurological disorders and CNS disorders and molecular therapeutics based diagnosis etc.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 14: Animal Models in Dementia

The animal models of dementia and Alzheimer's disease. for pre-clinical testing and clinical translation. Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease.

Keywords: Dementia Conferences | Vascular Dementia Conferences | Alzheimers Conferences | Neurology Conference | Dementia Congress | Neurological Disorders Conference

 

Session 15Neuro Oncology and CNS

It is a branch of Medical Sciences majorly deals with Neuro tumors. Deals with Studies related to Brain and Spinal cord neoplasms. Neuro-oncology and Pediatric Neuro-oncology are the two different Concepts that differentiate the determining methodology of Neuro tumors. Neuro-oncology mainly includes especially related topics like Radiation therapy, Neurosurgery, Neuroimaging, social, Psychological, Neuropathology and psychiatric aspects.

 

Visa Application

For conference attendance and participation only Business Visa should be applied. Contact your nearest travel agent/visa information center/ Czech Republic Embassy for the correct application form.

All visas for visiting / Czech Republic shall be processed by respective authorities only upon submission of proper documents through proper channel.

In case of non-furnishing of documents, non-adherence to guidelines visas shall be cancelled by respective authorities.

The minimum supportive documents that might be required while applying for / Czech Republic visa include:

Letter of invitation,

Abstract acceptance letter (if speaker),

Registration payment receipt,

Accommodation confirmation letter issued under conference letter head.

For letter of invitation and accommodation confirmation, payment of registration fees and accommodation charges is a pre-requisite.

Mandate documents required from conference secretariat should be obtained only through Rose Watson

For more details please contact

Rose Watson

Program Manager

Vascular Dementia 2020

E:  dementiaconference18@gmail.com

Past Conference Report

Vascular Dementia 2019

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date June 22-23, 2020

Speaker Opportunity

Past Conference Report

Supported By

Journal of Alzheimers Disease & Parkinsonism Journal of Neurological Disorders Journal of Neurology and Neuroscience

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Mail us at

Abstract Submission / Registration.
dementiaconference18@gmail.com
General Queries.
contact@europemeet.com
Sponsors / Exhibiting / Advertising.
Marketing@conferenceseries.com

Contact us at

Direct Call: +44 2039363178

Fill below form for Enquiry

Authorization Policy

By registering for the conference you grant permission to Conference Series LLC Ltd to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.